Status:
COMPLETED
A Dose-response Study of Dietary Resveratrol on Lipid Metabolism Disorder
Lead Sponsor:
Sun Yat-sen University
Conditions:
Dyslipidemias
Eligibility:
All Genders
35-70 years
Phase:
PHASE3
Brief Summary
In order to study the effect of resveratrol on the improvement of lipid and uric acid metabolism, randomized intervention trials were conducted to compare the effects of resveratrol on the improvement...
Detailed Description
In order to study the effect of resveratrol on the improvement of lipid and uric acid metabolism, randomized controlled trials were conducted to enrolled 160 patients with dyslipidemia. The subjects w...
Eligibility Criteria
Inclusion
- Dyslipidemia
- The age between 35 and 70 years old
Exclusion
- Intake of any medicine that affect lipid metabolism currently or in the preceding 6 months
- Dietary supplementation with phytochemicals including resveratrol in the preceding 3 months
- History of acute or chronic infectious disease, autoimmune disease, cancer, traumatic injury, or surgery in the preceding 1 month
- History of severe chronic disease including AS and CVD, liver or renal dysfunction, and lactation or pregnancy
- Pregnant woman and Breast Feeding Women
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
168 Patients enrolled
Trial Details
Trial ID
NCT04886297
Start Date
May 1 2021
End Date
September 30 2022
Last Update
October 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-Sen University
Guangzhou, Guangdong, China